Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | EW | TMO |
|---|
| Close | 89.28 | 648.43 |
| Market Cap | $51.5B | $240B |
| 1M | −1.68% | +10.75% |
| P/E (TTM) | 51.2 | 34.4 |
| Forward P/E | 29.8 | 21.8 |
| P/E 5-Yr Percentile | 98 | 65 |
| P/S | 7.9 | 5.2 |
| P/B | 4.9 | 4.6 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $1.7B | $12.0B |
| Revenue YoY | +13.6% | +10.5% |
| Gross Margin | 77.5% | — |
| Latest Quarter EPS | 0.42 | 4.68 |
| Avg Post-Earnings Move | ±3.9% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.34% | 2.36% |
| 90-Day Net Insider Buying | −$4.6M | −$38.9M |
EW · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
